A Multicenter Phase II Trial of Encorafenib, Binimetinib and Cetuximab for Early Relapsed Stage II/III BRAFV600E-mutated Colorectal Cancer: TRESBIEN trial (OGSG 2101)

Toshihiro Kudo, Shogen Boku, Atsushi Naito, Takashi Ohta, Yusuke Suwa, Ichiro Takemasa, Chiaki Inagaki, Koichi Okuya, Mitsuyoshi Tei, Masayoshi Nakanishi, Narikazu Boku, Hiroyuki Okuda, Toshifumi Yamaguchi, Shingo Noura, Yukinori Kurokawa, Toshio Shimokawa, Taroh Satoh, Hironaga Satake, Yoshinori Kagawa

ASCO2026, Chicago, IL May 29 – June 2, 2026

Warning: Trying to access array offset on false in /home/grwdev/grwdev.works/public_html/ogsg2026.grwdev.works/wp/wp-content/themes/OGSG/single.php on line 62